Category WTO/TRIPS

Global Fund And Tiered Medicines Pricing Under Debate

The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched an initiative with other agencies aimed at expanding global access to health products such as medicines. But the Fund has had some explaining to do about the initiative, which some say could encompass a plan to allow different prices based on national income levels.

Australia Accepts Indonesia WTO Dispute On Tobacco Packaging; Calls For Five Disputes To Be Joined

Australia yesterday took the unusual move of agreeing to the first request by Indonesia to establish a World Trade Organization dispute panel against it. The ready acceptance of the panel request was an attempt by Australia to bring the some or all of the five separate cases against its tobacco plain packaging law together for resource reasons and to protect the integrity of the WTO dispute settlement mechanism, it said in a statement to the Dispute Settlement Body.

WTO-WIPO IP Training Course For Governments

The World Trade Organization and World Intellectual Property Organization are jointly offering a course this week on all aspects of intellectual property to a group of officials from developing countries and countries in transition, the WTO has said.

TRIPS Council: Discussion Of IP And Innovation Irritates India: Other Issues Unchanged

World Trade Organization members at the WTO intellectual property committee this week held fast to positions on longstanding issues, but engaged in discussions on issues such as innovation in relation to universities, and so-called “non-violation complaints” against countries that may cause harm to another country but don’t violate a WTO rule. Also discussed was the ongoing dispute over plain packaging requirements for tobacco products.

EU Trademark Reform Delayed; Debate Includes Goods-In-Transit, Harmonisation

Efforts to update European Union trademark law have slowed amid political differences and squabbles over some provisions of the reform package, representatives from the European Commission (EC), European Parliament and trademark community say. Contrary to the wishes of the EC and lawmakers, the legislation will not be completed before European parliamentary elections in May.

Year Ahead: Biotech, IP Promise to Create Controversy From Farms To Big Pharma In 2014

The intersection of biotechnology and intellectual property continues to be a hot topic across the globe. From the patenting of certain plant varieties to human genes, to biodiversity and food security, to genetic resources, countries from developing to developed are attempting to navigate often blurred lines in terms of what can and cannot be patented, what should - and shouldn’t - be patented, and protecting innovators from farmers to plant breeders to drug manufacturers.

Global Health 2035 Report: Flawed Projections

Daniele Dionisio writes: Hopes that a comprehensive global health goal could be reached by 2035 are hardly credible with the load of unresolved issues still on the table. This article turns the spotlight on much-debated relevant questions that were left out or under-scrutinised in a recently published Lancet report.